Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Skin Melanoma”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Early research (Phase 1)Looking for participantsNCT06529822
What this trial is testing

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Who this might be right for
Muscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more
Washington University School of Medicine 64
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Not applicableLooking for participantsNCT05196087
What this trial is testing

Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)

Who this might be right for
Breast CancerMelanomaGastrointestinal Neuroendocrine Tumor
University Health Network, Toronto 500
Not applicableUnknownNCT01680562
What this trial is testing

In-vivo Optical Coherence Tomography Imaging in Dermatooncology

Who this might be right for
Non-melanocytic Skin TumorsMelanocytic Skin Tumors
Medical University of Vienna 37
Not applicableEnded earlyNCT00482105
What this trial is testing

Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells

Who this might be right for
Melanoma
University of California, Davis 7
Not applicableEnded earlyNCT01085396
What this trial is testing

Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin

Who this might be right for
Melanoma
University of Pittsburgh 16
Testing effectiveness (Phase 2)WithdrawnNCT05496192
What this trial is testing

Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer

Who this might be right for
MelanomaUrothelial Carcinoma
Bristol-Myers Squibb
Not applicableUnknownNCT03069846
What this trial is testing

Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope

Who this might be right for
Skin Cancer
Sung Hyun Pyun 150
Testing effectiveness (Phase 2)Study completedNCT00463892
What this trial is testing

High-resolution Magnetic Resonance Imaging (MRI) Scans to Look for Spread of Melanoma to Nearby Lymph Nodes

Who this might be right for
Melanoma
Redwood Regional Medical Group 200
Not applicableStudy completedNCT06079619
What this trial is testing

Comparison of Dermatoscopy X400 Interpreted by 6 Non-dermatologists and an Artificial Intelligence Software Skin Artificial Intelligence Versus Dermatoscopy x 20

Who this might be right for
Genital TumorPigmented Lesions
Centre Hospitalier Universitaire de Saint Etienne 157
Not applicableUnknownNCT05602337
What this trial is testing

A Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin Cancer

Who this might be right for
Melanoma and Other Malignant Neoplasms of Skin
DermTech 180
Not applicableStudy completedNCT05842421
What this trial is testing

Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors

Who this might be right for
Non-melanoma Skin Cancer
Technische Universität Dresden 250
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Not applicableLooking for participantsNCT07555210
What this trial is testing

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

Who this might be right for
Breast Cancer (Triple Negative Breast Cancer (TNBC))Renal Cell Carcinoma (Kidney Cancer)Melanoma (Skin Cancer)+5 more
Jessica Mezzanotte Sharpe 25
Not applicableActive Not RecruitingNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Not applicableStudy completedNCT04789421
What this trial is testing

Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management

Who this might be right for
Cutaneous Melanoma
Azienda Ospedaliero-Universitaria di Modena 3,248
Not applicableLooking for participantsNCT07318051
What this trial is testing

Sample Collection for Ongoing Research and Product Evaluation Study

Who this might be right for
Breast CancerLung CancerMuscle Invasive Bladder Cancer+9 more
Natera, Inc. 9,600
Not applicableStudy completedNCT02056522
What this trial is testing

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

Who this might be right for
Skin Lesions
Orlucent, Inc 357
Next Page